Clinical trial Recruiting at 3 sites Interventional Ages 18 to 75 Women only

Immediate Lymphatic Reconstruction to prevent breast cancer–related lymphedema

Official title: Prospective, Randomized Clinical Trial for Immediate Lymphatic Reconstruction to Prevent Breast Cancer Related Lymphedema

Run by University of South Florida · NCT07127003 · Data updated 2026-11-12

This will test whether doing Immediate Lymphatic Reconstruction during axillary lymph node removal can prevent lymphedema in women at high risk after breast cancer surgery.

More Breast Cancer Related Lymphedema trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexWomen only
Enrollment98 (estimated)
SponsorUniversity of South Florida
Academic / other
Drugs / interventionsradiation
Locations3 sites (Tampa, Florida and 2 other locations)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedOctober 1, 2026
Study endsOctober 1, 2027
Registry record updatedApril 30, 2026
Trial IDNCT07127003 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–75 undergoing or likely to require unilateral axillary lymph node dissection for breast cancer who are identified as high-risk by the tumor board and meet intraoperative criteria for lymphatic bypass are ideal candidates.

Probably not a fit

Patients with prior ALND, existing ipsilateral lymphedema, those only treated with sentinel node biopsy, those requiring bilateral ALND, male patients, or non-English speakers (per protocol exclusions) would not be expected to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, blinded trial enrolling high-risk women identified by a multidisciplinary tumor board who are undergoing or likely to require axillary lymph node dissection. Participants undergo baseline lymphedema screening with bioimpedance spectroscopy, circumferential limb measurements, and 3D infrared perometry, then are randomized to ILR performed at the time of ALND or to no ILR. Surgery uses RAM to identify lymphatic channels and a microvascular lymphatic-to-venous bypass is performed when suitable lymphatics and veins are found. The study will compare incidence of breast cancer–related lymphedema, safety outcomes, and patient-reported quality of life between the two arms.

Why it matters

Potential benefit: If successful, adding ILR at the time of axillary dissection could substantially reduce the rate of lymphedema and help preserve arm function and quality of life for high-risk patients.

How similar studies have gone: Single-center and observational series of immediate lymphatic reconstruction (LYMPHA) have reported lower lymphedema rates, but randomized data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients consenting for unilateral ALND \[prior history of sentinel lymph node biopsy (SLNBx) allowed if \<6 months from consent\]
* Patients consenting for unilateral SLNBx with possible ALND, with a clinically or radiographically positive lymph node OR a high likelihood of ALND per the Breast Surgeon
* Identification of at least one transected lymphatic channel and at least one vein to be used for bypass at the time of ALND during surgery
* Female breast cancer patients 18-75 years of age (inclusive)

Exclusion Criteria:

* • Male breast cancer patients

  * Non-English speaking participants
  * Female breast cancer patients with axillary recurrence
  * Female breast cancer patients who have a history of ALND
  * Female patients requiring bilateral ALND for the treatment of their breast cancer
  * Female breast patients treated with SLNBx only
  * Primary lymphedema of the affected upper limb
  * Secondary lymphedema of the affected limb prior to the lymphadenectomy
  * Radiotherapy at the axilla before the study / surgery
  * Life expectancy \< 2 years for any reason
  * Pregnancy or nursing
  * Substance abuse (such as alcohol or drug abuse) within 6 months prior to screening
  * Severe psychiatric disease
  * Distant metastases at the time of preoperative screening

Where it's running

  • Tampa General Hospital
    Tampa, Florida, United States
    Recruiting
  • Moffitt Cancer Center
    Tampa, Florida, United States
    Recruiting
  • University of South Florida
    Tampa, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.